BioMarin Pharmaceutical and CollPlant Biotechnologies Listed on Nasdaq
1 report, 1 independent
Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioMarin Pharmaceutical and CollPlant Biotechnologies are both listed on Nasdaq and are being compared as healthcare companies. A report comparing the two companies analyzed their profitability, risk profiles, and institutional ownership levels.
From themarketsdaily.com
Why it matters
The comparison highlights differences in market perception, with analysts favoring CollPlant Biotechnologies due to its higher consensus target price and probable upside. BioMarin Pharmaceutical shows significantly lower volatility compared to CollPlant Biotechnologies.
From themarketsdaily.com
Who's involved
- BioMarin PharmaceuticalAmerican healthcare company listed on Nasdaq
- NasdaqAmerican fully electronic stock exchange where the companies are listed
Keep exploring
The entities involved
-
BioMarin Pharmaceutical
American company
-
Nasdaq
American fully electronic stock exchange
Related events
- Praxis Precision Medicines and Relay Therapeutics were listed on the Nasdaq stock exchange on October 1, 2026.
- Company Q783794 was listed on the Nasdaq stock exchange.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- Mentari Therapeutics, Inc. was listed on the Nasdaq stock exchange on November 4, 2026.
- INmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.